{"transactions":[{"id":3385256,"issuer":{"id":7283,"kind":"organization","name":"Stablecoin Development Corp","symbol":"SDEV"},"owners":[{"id":154161,"kind":"person","name":"Zavodnick Todd Erik","position":1,"cik":"0001660467","reported_name":"Zavodnick Todd Erik","relationship":{"director":true}}],"security":"Stock option (right to buy)","published_at":"2019-10-30T20:31:06.000Z","date":"2019-05-30","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest in 12 equal monthly installments beginning on the grant date."}],"balance_after":20000,"derivative":{"exercise_price":0.3,"exercise_date":"2019-05-30","expiration_date":"2029-05-30","underlying":"Common stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001437749-19-020935","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1389545/000143774919020935/rdgdoc.xml","form_type":"4"}},{"id":3788332,"issuer":{"id":83521,"kind":"organization","name":"Revance Therapeutics, Inc.","symbol":"RVNC"},"owners":[{"id":154161,"kind":"person","name":"Zavodnick Todd Erik","position":1,"cik":"0001660467","reported_name":"Zavodnick Todd Erik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CCO & President,","other_text":"Aesthetics & Theraputics"}}],"security":"Common Stock","published_at":"2018-10-17T18:53:25.000Z","date":"2018-10-15","kind":"tax_withholding","acquired":false,"shares":7093,"price":23.94,"value":169806.42,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Represents the number of shares withheld by and surrendered by Mr. Zavodnick to the Issuer on October 15, 2018, to satisfy tax withholding obligations that arose in connection with the vesting of a 2017 Restricted Stock Award (\"RSA\") for 95,000 shares.  The RSA vests in four equal annual installments from October 15, 2017, subject to Mr. Zavodnick's Continuous Service (as defined in the Issuer's 2014 Inducement Plan) on each vesting date."}],"balance_after":96407,"source":{"system":"sec-edgar","filing":"0001628280-18-012608","document":"wf-form4_153981679009475.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1479290/000162828018012608/wf-form4_153981679009475.xml","form_type":"4"}},{"id":3907830,"issuer":{"id":7283,"kind":"organization","name":"Stablecoin Development Corp","symbol":"SDEV"},"owners":[{"id":154161,"kind":"person","name":"Zavodnick Todd Erik","position":1,"cik":"0001660467","reported_name":"Zavodnick Todd Erik","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2018-06-04T20:22:51.000Z","date":"2018-05-31","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options will vest in 12 equal monthly installments."}],"balance_after":53698,"derivative":{"exercise_price":2.2,"exercise_date":"2018-06-30","expiration_date":"2028-05-31","underlying":"common stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001437749-18-011213","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1389545/000143774918011213/rdgdoc.xml","form_type":"4"}},{"id":4068536,"issuer":{"id":83521,"kind":"organization","name":"Revance Therapeutics, Inc.","symbol":"RVNC"},"owners":[{"id":154161,"kind":"person","name":"Zavodnick Todd Erik","position":1,"cik":"0001660467","reported_name":"Zavodnick Todd Erik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CCO & President,","other_text":"Aesthetics & Theraputics"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-02-09T21:12:27.000Z","date":"2018-02-08","kind":"grant","acquired":true,"shares":48750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the stock option shall vest in forty-eight (48) equal monthly installments beginning from February 8, 2018, subject to Mr. Zavodnick's Continuous Service (as defined in the Plan) on each vesting date."}],"balance_after":48750,"derivative":{"exercise_price":29.15,"expiration_date":"2028-02-07","underlying":"Common Stock","underlying_shares":48750},"source":{"system":"sec-edgar","filing":"0001479290-18-000017","document":"wf-form4_151822873290802.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1479290/000147929018000017/wf-form4_151822873290802.xml","form_type":"4"}},{"id":4068535,"issuer":{"id":83521,"kind":"organization","name":"Revance Therapeutics, Inc.","symbol":"RVNC"},"owners":[{"id":154161,"kind":"person","name":"Zavodnick Todd Erik","position":1,"cik":"0001660467","reported_name":"Zavodnick Todd Erik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CCO & President,","other_text":"Aesthetics & Theraputics"}}],"security":"Common Stock","published_at":"2018-02-09T21:12:27.000Z","date":"2018-02-08","kind":"grant","acquired":true,"shares":8500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares subject to the Restricted Stock award shall vest in three (3) equal annual installments beginning from March 15, 2018, subject to Mr. Zavodnick's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan(the \"Plan\")) on each vesting date."}],"balance_after":103500,"source":{"system":"sec-edgar","filing":"0001479290-18-000017","document":"wf-form4_151822873290802.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1479290/000147929018000017/wf-form4_151822873290802.xml","form_type":"4"}},{"id":4204818,"issuer":{"id":83521,"kind":"organization","name":"Revance Therapeutics, Inc.","symbol":"RVNC"},"owners":[{"id":154161,"kind":"person","name":"Zavodnick Todd Erik","position":1,"cik":"0001660467","reported_name":"Zavodnick Todd Erik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-09-20T20:52:56.000Z","date":"2017-09-18","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the stock option shall vest over a period of four years commencing September 18, 2017, with 25% vesting on the annual anniversary of the vesting commencement date and 1/48th vesting each month thereafter over the remaining three years, subject to Mr. Zavodnick's Continuous Service (as defined in the Plan) through each such vesting date."}],"balance_after":35000,"derivative":{"exercise_price":24.4,"expiration_date":"2027-09-17","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001209191-17-053533","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1479290/000120919117053533/doc4.xml","form_type":"4"}},{"id":4204817,"issuer":{"id":83521,"kind":"organization","name":"Revance Therapeutics, Inc.","symbol":"RVNC"},"owners":[{"id":154161,"kind":"person","name":"Zavodnick Todd Erik","position":1,"cik":"0001660467","reported_name":"Zavodnick Todd Erik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2017-09-20T20:52:56.000Z","date":"2017-09-18","kind":"grant","acquired":true,"shares":95000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock award (the \"RSA\"). The shares underlying the RSA shall vest over a period of four years commencing October 15, 2017, with 25% vesting each year on the annual anniversary of the vesting commencement date, subject to Mr. Zavodnick's Continuous Service (as defined in the Issuer's Amended and Restated 2014 Inducement Plan (the \"Plan\")) through each such vesting date."}],"balance_after":95000,"source":{"system":"sec-edgar","filing":"0001209191-17-053533","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1479290/000120919117053533/doc4.xml","form_type":"4"}},{"id":4342040,"issuer":{"id":176636,"kind":"organization","name":"Zeltiq Aesthetics Inc","symbol":"ZLTQ"},"owners":[{"id":154161,"kind":"person","name":"Zavodnick Todd Erik","position":1,"cik":"0001660467","reported_name":"Zavodnick Todd Erik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, International"}}],"security":"Stock Option (right to buy)","published_at":"2017-04-28T13:56:07.000Z","date":"2017-04-28","kind":"disposition_to_issuer","acquired":false,"shares":16674,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In connection with the Merger, the Board accelerated and vested in full all equity awards held by the Reporting Person as of immediately prior to the closing of the Merger. Pursuant to the terms of the Merger Agreement, all shares subject to this option were canceled and converted into the right to receive $56.50 per share in cash, without interest and subject to any applicable withholding of taxes."}],"balance_after":0,"derivative":{"exercise_price":40.89,"expiration_date":"2027-01-17","underlying":"Common Stock","underlying_shares":16674},"source":{"system":"sec-edgar","filing":"0001209191-17-028628","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1415336/000120919117028628/doc4.xml","form_type":"4"}},{"id":4342039,"issuer":{"id":176636,"kind":"organization","name":"Zeltiq Aesthetics Inc","symbol":"ZLTQ"},"owners":[{"id":154161,"kind":"person","name":"Zavodnick Todd Erik","position":1,"cik":"0001660467","reported_name":"Zavodnick Todd Erik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, International"}}],"security":"Common Stock","published_at":"2017-04-28T13:56:07.000Z","date":"2017-04-28","kind":"disposition_to_issuer","acquired":false,"shares":99971,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposed of pursuant to the Agreement and Plan of Merger, dated as of February 13, 2017, by and among Allergan Holdco US, Inc. a wholly owned subsidiary of Allergan plc (\"Allergan\"), Blizzard Merger Sub, Inc. (\"Merger Sub\"), and the Issuer (the \"Merger Agreement\"), as approved by the board of directors of the Issuer (the \"Board\"), whereby Merger Sub merged with and into the Issuer, with the Issuer continuing on as the surviving corporation (the \"Merger\"). In connection with the Merger, the Board accelerated and vested in full all equity awards held by the Reporting Person as of immediately prior to the closing of the Merger. Pursuant to the terms of the Merger Agreement, all 99,971 shares were canceled and converted into the right to receive $56.50 per share in cash, without interest and subject to any applicable withholding of taxes."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Disposed of pursuant to the Agreement and Plan of Merger, dated as of February 13, 2017, by and among Allergan Holdco US, Inc. a wholly owned subsidiary of Allergan plc (\"Allergan\"), Blizzard Merger Sub, Inc. (\"Merger Sub\"), and the Issuer (the \"Merger Agreement\"), as approved by the board of directors of the Issuer (the \"Board\"), whereby Merger Sub merged with and into the Issuer, with the Issuer continuing on as the surviving corporation (the \"Merger\"). In connection with the Merger, the Board accelerated and vested in full all equity awards held by the Reporting Person as of immediately prior to the closing of the Merger. Pursuant to the terms of the Merger Agreement, all 99,971 shares were canceled and converted into the right to receive $56.50 per share in cash, without interest and subject to any applicable withholding of taxes."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-17-028628","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1415336/000120919117028628/doc4.xml","form_type":"4"}},{"id":4417442,"issuer":{"id":176636,"kind":"organization","name":"Zeltiq Aesthetics Inc","symbol":"ZLTQ"},"owners":[{"id":154161,"kind":"person","name":"Zavodnick Todd Erik","position":1,"cik":"0001660467","reported_name":"Zavodnick Todd Erik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, International"}}],"security":"Common Stock","published_at":"2017-02-28T11:08:15.000Z","date":"2017-02-24","kind":"tax_withholding","acquired":false,"shares":7815,"price":55.62,"value":434670.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares withheld by and surrendered to the Issuer on February 24, 2017, to satisfy tax withholding obligations that arose in connection with the vesting of the Restricted Stock Units (the \"RSUs\") granted on February 1, 2016 for 99,049 shares. The RSUs vest in four equal annual installments beginning February 1, 2016."}],"balance_after":99971,"source":{"system":"sec-edgar","filing":"0001209191-17-015088","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1415336/000120919117015088/doc4.xml","form_type":"4"}},{"id":4485230,"issuer":{"id":176636,"kind":"organization","name":"Zeltiq Aesthetics Inc","symbol":"ZLTQ"},"owners":[{"id":154161,"kind":"person","name":"Zavodnick Todd Erik","position":1,"cik":"0001660467","reported_name":"Zavodnick Todd Erik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, International"}}],"security":"Stock Option (right to buy)","published_at":"2017-01-20T19:09:31.000Z","date":"2017-01-18","kind":"grant","acquired":true,"shares":16674,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the total number of shares subject to the option vest on January 18, 2018, and the remainder vest in equal monthly installments over a 36-month period thereafter, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":16674,"derivative":{"exercise_price":40.89,"expiration_date":"2027-01-17","underlying":"Common Stock","underlying_shares":16674},"source":{"system":"sec-edgar","filing":"0001209191-17-004985","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1415336/000120919117004985/doc4.xml","form_type":"4"}},{"id":4485229,"issuer":{"id":176636,"kind":"organization","name":"Zeltiq Aesthetics Inc","symbol":"ZLTQ"},"owners":[{"id":154161,"kind":"person","name":"Zavodnick Todd Erik","position":1,"cik":"0001660467","reported_name":"Zavodnick Todd Erik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, International"}}],"security":"Common Stock","published_at":"2017-01-20T19:09:31.000Z","date":"2017-01-18","kind":"grant","acquired":true,"shares":8737,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents grant of restricted stock units payable solely in common stock that vest in four equal annual installments, with the vesting commencement date of January 18, 2017."}],"balance_after":107786,"source":{"system":"sec-edgar","filing":"0001209191-17-004985","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1415336/000120919117004985/doc4.xml","form_type":"4"}},{"id":4501645,"issuer":{"id":7283,"kind":"organization","name":"Stablecoin Development Corp","symbol":"SDEV"},"owners":[{"id":154161,"kind":"person","name":"Zavodnick Todd Erik","position":1,"cik":"0001660467","reported_name":"Zavodnick Todd Erik","relationship":{"director":true}}],"security":"stock option (right to buy)","published_at":"2017-01-04T23:15:09.000Z","date":"2017-01-03","kind":"grant","acquired":true,"shares":22359,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Granted pursuant to the 2007 Omnibus Incentive Plan and the 2017 NonEmployee\nDirector Compensation Plan"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"stock options will vest in equal month installments starting on the date of grant"}],"balance_after":33699,"derivative":{"exercise_price":3.24,"exercise_date":"2017-01-03","expiration_date":"2027-01-03","underlying":"Common Stock","underlying_shares":22359},"source":{"system":"sec-edgar","filing":"0001437749-17-000193","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1389545/000143774917000193/rdgdoc.xml","form_type":"4"}},{"id":4586077,"issuer":{"id":7283,"kind":"organization","name":"Stablecoin Development Corp","symbol":"SDEV"},"owners":[{"id":154161,"kind":"person","name":"Zavodnick Todd Erik","position":1,"cik":"0001660467","reported_name":"Zavodnick Todd Erik","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2016-10-04T22:20:53.000Z","date":"2016-10-03","kind":"grant","acquired":true,"shares":247,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Amended Form 4 filed to fix the share amount on previous filing. Grant should be in the amount of 247, not 3303."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amended Form 4 to state that total stock options held is 11,340 shares, not 14,396 as previously reported."}],"balance_after":11367,"derivative":{"exercise_price":3.99,"exercise_date":"2016-11-01","expiration_date":"2026-10-03","underlying":"common stock","underlying_shares":247},"source":{"system":"sec-edgar","filing":"0001437749-16-039486","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1389545/000143774916039486/rdgdoc.xml","form_type":"4/A","original_submission_date":"2016-10-04"}},{"id":4586075,"issuer":{"id":7283,"kind":"organization","name":"Stablecoin Development Corp","symbol":"SDEV"},"owners":[{"id":154161,"kind":"person","name":"Zavodnick Todd Erik","position":1,"cik":"0001660467","reported_name":"Zavodnick Todd Erik","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2016-10-04T21:34:46.000Z","date":"2016-10-03","kind":"grant","acquired":true,"shares":3303,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Granted pursuant to the 2007 Omnibus Incentive Plan and the 2016 NonEmployee\nDirector Compensation Plan"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock options will vest in equal monthly installments over the remainder of the year starting from the date of grant"}],"balance_after":14396,"derivative":{"exercise_price":3.99,"exercise_date":"2016-11-01","expiration_date":"2026-10-03","underlying":"common stock","underlying_shares":3303},"source":{"system":"sec-edgar","filing":"0001437749-16-039484","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1389545/000143774916039484/rdgdoc.xml","form_type":"4"}}]}